ProQuest Investments IV, L.P., 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 28,870 shares at $63.14 ($1.8M) on 2016-08-23, disclosed to the SEC on 2016-08-25.
Open-market sale of $1.8M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.12 | 34 | $2K | 0.1% |
| 2 | $63.12 | 113 | $7K | 0.4% |
| 3 | $63.14 | 17,118 | $1.1M | 59.4% |
| 4 | $62.78 | 23 | $1K | 0.1% |
| 5 | $62.78 | 76 | $5K | 0.3% |
| 6 | $62.78 | 11,506 |
| $722K |
| 39.7% |
| Total | $63.00 avg | 28,870 | $1.8M | 100% |
| Filing → |
| EGRX | SELL | 2016-10-04 | $1.5M | — | Filing → |
| EGRX | SELL | 2016-09-23 | $13.2M | — | Filing → |
| EGRX | SELL | 2016-08-17 | $6.1M | — | Filing → |